Mammary gland proliferation in female rats: Effects of the estrous cycle, pseudo-pregnancy and age

Experimental and Toxicologic Pathology

Volumn 64, Issue 4, 2012, Pages 321-332

  Hvid, Henning ^a,b   Thorup, Inger ^b   Sjögren, Ingrid ^b   Oleksiewicz, Martin B ^c   Jensen, Henrik E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c INTERCELL AG   (Austria)

Author keywords

Estrous cycle; Proliferation; Pseudo pregnancy; Rat mammary gland; Terminal end buds; Toxicologic pathology

Indexed keywords

BROXURIDINE; CYCLINE; KI 67 ANTIGEN;

AGE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; DIESTRUS; ESTRUS; ESTRUS CYCLE; FEMALE; GENITAL SYSTEM; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MAMMARY GLAND PROLIFERATION; METESTRUS; NONHUMAN; PROESTRUS; PSEUDOPREGNANCY; RAT; SPRAGUE DAWLEY RAT; UDDER; VAGINA SMEAR;

AGE FACTORS; AGING; ANIMALS; BIOLOGICAL MARKERS; BROMODEOXYURIDINE; CELL PROLIFERATION; ESTROUS CYCLE; FEMALE; KI-67 ANTIGEN; MAMMARY GLANDS, ANIMAL; PROLIFERATING CELL NUCLEAR ANTIGEN; PSEUDOPREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 84859425999     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.09.005     Document Type: Article

References (51)

1. Altman D.G. Practical statistics for medical research 1991, first edition.
2. Altman D.G., Bland J.M. Measurement in medicine: the analysis of method comparison studies. Statistician 1983, 32:307-317.
3. Anderson E., Clarke R.B., Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia 1998, 3:23-35.
4. Bibby B.M., Martinussen T., Skovgaard I.M. Experimental design in the agricultural sciences 2004, First.
5. Bolander F.F. Differential characteristics of the thoracic and abdominal mammary glands from mice. Exp Cell Res 1990, 189:142-144.
6. Brisken C., Heineman A., Chavarria T., Elenbaas B., Tan J., Dey S.K., et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 2000, 14:650-654.
7. Bromley M., Rew D., Becciolini A., Balzi M., Chadwick C., Hewitt D., et al. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa. Eur J Histochem 1996, 40:89-100.
8. Butcher R.L., Collins W.E., Fugo N.W. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology 1974, 94:1704-1708.
9. Christov K., Grubbs C.J., Shilkaitis A., Juliana M.M., Lubet R.A. Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model. Clin Cancer Res 2007, 13:5488-5496.
10. Clarke R.B. Steroid receptors and proliferation in the human breast. Steroids 2003, 68:789-794.
11. Conneely O.M., Mulac-Jericevic B., rnett-Mansfield R. Progesterone signaling in mammary gland development. Ernst Schering Found Symp Proc 2007, 45-54.
12. Danish Ministry of Justice. The Care and Housing of Laboratory Animals/Bekendtgørelse om forsøgsdyrs pasning og opstaldning og om anvendelse af udryddelsestruede og vildtlevende dyr til forsøg mv, BEK nr. 687 af 25/7/2003; 2003.
13. Dulbecco R., Henahan M., Armstrong B. Cell types and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 1982, 79:7346-7350.
14. EMEA/CPMP. Points to consider document on the non-clinical assessment of the carcinogenic potential of insulin analogues. 2001; CPMP/SWP/372/01.
15. Estes K.S., Simpkins J.W., Chen C.L. Alteration in pulsatile release of LH in aging female rats. Proc Soc Exp Biol Med 1980, 163:384-387.
16. Everett J.W. Reinstatement of estrous cycles in middle-aged spontaneously persistent estrous rats: importance of circulating prolactin and the resulting facilitative action of progesterone. Endocrinology 1980, 106:1691-1696.
17. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988, 96:857-881.
18. Hartman C.G. Some new observations on the vaginal smear of the rat. Yale J Biol Med 1944, 17:99-111.
19. Heidebrecht H.J., Buck F., Haas K., Wacker H.H., Parwaresch R. Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the 'Ki-67' proteins. Cell Prolif 1996, 29:413-425.
20. Huang H.H., Meites J. Reproductive capacity of aging female rats. Neuroendocrinology 1975, 17:289-295.
21. Hvid H., Thorup I., Oleksiewicz M.B., Sjögren I., Jensen H.E. An alternative method for preparation of tissue sections from the rat mammary gland. Exp Toxcol Pathol 2010, 10.1016/j.etp.2010.02.005.
22. Kacew S., Ruben Z., McConnell R.F. Strain as a determinant factor in the differential responsiveness of rats to chemicals. Toxicol Pathol 1995, 23:701-714.
23. Kleinberg D.L. Role of IGF-I in normal mammary development. Breast Cancer Res Treat 1998, 47:201-208.
24. Kleinberg D.L., Ruan W. IGF-I, GH, and sex steroid effects in normal mammary gland development. J Mammary Gland Biol Neoplasia 2008, 13:353-360.
25. Long J.A., Evans H.M. The oestrous cycle in the rat and its associated phenomena. Mem Univ Calif 1922, 6:1-148.
26. Lu K.H., Hopper B.R., Vargo T.M., Yen S.S. Chronological changes in sex steroid, gonadotropin and prolactin secretions in aging female rats displaying different reproductive states. Biol Reprod 1979, 21:193-203.
27. Mallepell S., Krust A., Chambon P., Brisken C. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 2006, 103:2196-2201.
28. Mandl A.M. The phases of the oestrous cycle in the adult white rat. J Exp Biol 1951, 28:576-584.
29. Marcondes F.K., Bianchi F.J., Tanno A.P. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 2002, 62:609-614.
30. Masso-Welch P.A., Darcy K.M., Stangle-Castor N.C., Ip M.M. A developmental atlas of rat mammary gland histology. J Mammary Gland Biol Neoplasia 2000, 5:165-185.
31. OECD Guidance document for histological evaluation of endocrine and reproductive tests in rodents, number 106. Part 5. preparation, reading and reporting of vaginal smears 2009.
32. Pompei L.M., Carvalho F.M., Ortiz S.C., Motta M.C., Cruz R.J., Melo N.R. Morphometric evaluation of effects of two sex steroids on mammary gland of female rats. Maturitas 2005, 51:370-379.
33. Popesko P., Rajtová V., Horák J. Atlas of the anatomy of small laboratory animals 1992, vol. 2. Rat, Mouse and Golden Hamster. first edition.
34. Rakatzi I., Ramrath S., Ledwig D., Dransfeld O., Bartels T., Seipke G., et al. A novel insulin analogue with unique properties: LysB3, GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin substrate 1. Diabetes 2003, 52:2227-2238.
35. Ruan W., Catanese V., Wieczorek R., Feldman M., Kleinberg D.L. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid. Endocrinology 1995, 136:1296-1302.
36. Ruan W., Monaco M.E., Kleinberg D.L. Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 2005, 146:1170-1178.
37. Ruehl-Fehlert C., Kittel B., Morawietz G., Deslex P., Keenan C., Mahrt C.R., et al. Revised guides for organ sampling and trimming in rats and mice-part 1. Exp Toxicol Pathol 2003, 55:91-106.
38. Russo I.H., Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 1996, 104:938-967.
39. Russo J., Ao X., Grill C., Russo I.H. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 1999, 53:217-227.
40. Russo J., Russo I.H. DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J Natl Cancer Inst 1978, 61:1451-1459.
41. Russo J., Russo I.H. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol 1980, 100:497-512.
42. Russo J., Russo I.H. Biological and molecular bases of mammary carcinogenesis. Lab Invest 1987, 57:112-137.
43. Schedin P., Mitrenga T., Kaeck M. Estrous cycle regulation of mammary epithelial cell proliferation, differentiation, and death in the Sprague-Dawley rat: a model for investigating the role of estrous cycling in mammary carcinogenesis. J Mammary Gland Biol Neoplasia 2000, 5:211-225.
44. Shelesnyak M.C. The induction of pseudopregnancy in the rat by means of electrical stimulation. Anat Rec 1931, 49:179-183.
45. Shyamala G., Ferenczy A. Mammary fat pad may be a potential site for initiation of estrogen action in normal mouse mammary glands. Endocrinology 1984, 115:1078-1081.
46. Silberstein G.B., Van H.K., Hrabeta-Robinson E., Compton J. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system. J Endocrinol 2006, 190:225-239.
47. Stammberger I., Seipke G., Bartels T. Insulin glulisine-a comprehensive preclinical evaluation. Intl J Toxicol 2006, 25:25-33.
48. Strange R., Westerlind K.C., Ziemiecki A., Andres A.C. Proliferation and apoptosis in mammary epithelium during the rat oestrous cycle. Acta Physiol (Oxf) 2007, 190:137-149.
49. Westwood F.R. The female rat reproductive cycle: a practical histological guide to staging. Toxicol Pathol 2008, 36:375-384.
50. Yu C.C., Woods A.L., Levison D.A. The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J 1992, 24:121-131.
51. Zacchetti A., van G.E., Teske E., Nederbragt H., Dierendonck J.H., Rutteman G.R. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry. APMIS 2003, 111:430-438.